# A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome

> **NCT05188274** · NA · UNKNOWN · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Tourette Syndrome in Children
- Tourette Syndrome in Adolescence

## Interventions

- **DIETARY_SUPPLEMENT:** T92
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05188274
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05
- **Primary completion:** 2024-02
- **Final completion:** 2024-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188274, "A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05188274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*